Entrada Therapeutics TRDA
NASDAQ TRDA
$5.44 +0.19 (+3.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entrada Therapeutics (TRDA) Gains (Losses) on Sale of Assets & Investments (2022 - 2026)

Updated

Analysis

Entrada Therapeutics (TRDA) Gains (Losses) on Sale of Assets & Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Entrada Therapeutics 205.54 Mn -172.82 Mn - -122,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -122,000.00
Jun 30, 2026 -180,000.00
Mar 31, 2026 -406,000.00
Dec 31, 2025 31,000.00
Sep 30, 2025 221,000.00
Jun 30, 2025 -37,000.00
Mar 31, 2025 480,000.00
Dec 31, 2024 -1.02 Mn
Sep 30, 2024 1.30 Mn
Jun 30, 2024 -83,000.00
Mar 31, 2024 -441,000.00
Dec 31, 2023 691,000.00
Sep 30, 2023 509,000.00
Jun 30, 2023 -363,000.00
Mar 31, 2023 1.42 Mn
Dec 31, 2022 690,000.00
Sep 30, 2022 -482,000.00
Jun 30, 2022 -730,000.00
Mar 31, 2022 -1.54 Mn
API Access

Entrada Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TRDA&period=max&api_key=YOUR_API_KEY